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Introduction
Whether atherosclerosis is increased or not in Familial
Mediterranean Fever (FMF) is a much debated issue.
Carotid artery intima media thickness (IMT) a surrogate
marker for subclinical atherosclerosis is found to be
increased in a number of studies [1-5], however this
contrasts with the lack of increased frequency of athero-
sclerotic plaques[1-5]. Also, population surveys do not
indicate an increased prevalence of ischaemic heart disease
in FMF patients. In the current study, we hypothesized
that FMF patients with no apparent atherosclerotic risk
factor would have no increase in the carotid artery IMT.
Objectives
To investigate markers of carotid atherosclerosis and oxi-
dized low density lipoprotein (oxLDL) levels in patients
with FMF who have no risk factors for cardiovascular
disease.
Methods
We studied 44 patients (25 F/19 M; mean age: 33.5±7.5)
with FMF in attack free period and gender and age
matched 44 healthy subjects (25 F/19 M; mean age: 33.4
±7.0). Exclusion criteria were clinical coronary artery
disease, chronic renal disease, diabetes mellitus, hyper-
tension, history of myocardial infarction, angina pectoris
or cerebrovascular disease, dyslipidemia, metabolic syn-
drome or active infection. Those who were in postme-
nopausal status and using antilipid drugs were also
excluded. We measured carotid artery IMT and investi-
gated presence or absence of atherosclerotic plaques in
the carotids, using Doppler ultrasound. We also assessed
serum lipid and OxLDL levels.
Results
Mean disease duration of the FMF patients was 20±9
years. The mean carotid IMT (C-IMT) did not differ
between patients and controls (0.52±0.10 mm vs 0.53
±0.06 mm, respectively, P=0.709). None of the patients
or controls had atherosclerotic plaques. Total and LDL
cholesterol levels were significantly lower among
patients compared to controls (total cholesterol: 157.07
±34.18 vs 181.05±36.79, respectively, P=0.002; LDL cho-
lesterol: 100.48±30.13 vs 126.25±34.05, respectively,
P=0.001). Whereas OxLDL levels were significantly
higher in FMF patients (337.48±438.56 ng/dl) when
compared to controls (156.19±383.24 ng/dl), (P=0.044).
There was no correlation between CIMT and OxLDL
levels among both patients (r= -0.156, p=0.324) and
controls (r=-0.196, p=0.246).
Conclusion
Our study supports further evidence for no increased
atherosclerosis in FMF. As previously shown patients
with FMF have low cholesterol levels when compared to
healthy controls [1,2]. On the other hand, increased
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